Skip to main content
Clinical Trials/NCT04620876
NCT04620876
Recruiting
Not Applicable

Bimodal and Coaxial High Resolution Ophtalmic Imaging

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts1 site in 1 country1,200 target enrollmentOctober 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Retinitis Pigmentosa
Sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Enrollment
1200
Locations
1
Primary Endpoint
Visualization and image analysis of a structure of interest
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

The knowledge of the pathogenesis of retinal affections, a major cause of blindness, has greatly benefited from recent advances in retinal imaging. However, optical aberrations of the ocular media limit the resolution that can be achieved by current techniques.

The use of an adaptive optics system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many retinal microstructures: photoreceptors, vessels, bundles of nerve fibers.

Recently, the development of the coupling of the two main imaging techniques, the Adaptive Optics Ophthalmoscope with Optical Coherence Tomography, enables unparalleled three-dimensional in vivo cell-scale imaging, while remaining comfortable for the patients.

The purpose of this project is to evaluate the performance of this system for imaging micrometric retinal structures.

Detailed Description

The goal of the project is the capture and analysis of images with AOSLO system, in order to evaluate the performance of this system compared to OCT imaging devices and existing Adaptive Optics used at National Hospital of Ophthalmology.

Registry
clinicaltrials.gov
Start Date
October 1, 2019
End Date
October 15, 2024
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • People over 18
  • Patient with a pathology affecting the eye or healthy volunteer
  • Participant who signed the consent
  • Beneficiaries of the health insurance
  • Exclusion Criteria
  • Patients with a history of photosensitivity.
  • Patients who have just received a photodynamic therapy treatment
  • Patients taking drugs with photosensitivity as a side effect.
  • Persons with pacemakers or other implanted electronic medical device
  • Patients with viral conjunctivitis or any other infectious disease.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Visualization and image analysis of a structure of interest

Time Frame: From date of inclusion until the date of last documented progression , assessed up to 5 years

The visualization of the structure of interest in at least one area of the image will be considered the main criterion of success.

Study Sites (1)

Loading locations...

Similar Trials